Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0–2-month-old low birth weight infants in India—the “ProSPoNS” Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial

Table 1 Schedules for study subject enrolment, intervention, and assessments

^†Infant stool samples collected from one participating site (preferably in Delhi) at time of enrolment (day 0), at end of 3rd week of supplementation (day 21), and at end of follow-up (within day 56–60)
^††Daily during the first week of life, thrice a week from week 2 of life till the end of the first month, and subsequently weekly in the second month

ISSN: 1745-6215